Page 154 - Read Online

Page 14 of 17 Sharma et al. Microbiome Res Rep 2024;3:3 https://dx.doi.org/10.20517/mrr.2023.51

DECLARATIONS
Authors’ contributions
Literature search, manuscript preparation, review, and editing of the final draft: Sharma D, Gajjar D
Conceptualization of the article, literature search, manuscript preparation, review, and editing of the final
draft: Seshadri S

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflict of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Sgorbati B, Biavati B, Palenzona D. The genus Bifidobacterium. In: Wood BJB, Holzapfel WH, editors. The Genera of Lactic Acid
Bacteria. Boston: Springer US; 1995. p. 279-306. DOI
2. Colston JM, Taniuchi M, Ahmed T, et al. Intestinal colonization with Bifidobacterium longum subspecies is associated with length at
birth, exclusive breastfeeding, and decreased risk of enteric virus infections, but not with histo-blood group antigens, oral vaccine
response or later growth in three birth cohorts. Front Pediatr 2022;10:804798. DOI PubMed PMC
3. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota
across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010;107:11971-5. DOI PubMed PMC
4. Guaraldi F, Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol
2012;2:94. DOI PubMed PMC
5. Nowak A, Paliwoda A, Błasiak J. Anti-proliferative, pro-apoptotic and anti-oxidative activity of Lactobacillus and Bifidobacterium
strains: a review of mechanisms and therapeutic perspectives. Crit Rev Food Sci Nutr 2019;59:3456-67. DOI PubMed
6. Coutzac C, Jouniaux JM, Paci A, et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with
cancer. Nat Commun 2020;11:2168. DOI PubMed PMC
7. Asadollahi P, Ghanavati R, Rohani M, Razavi S, Esghaei M, Talebi M. Anti-cancer effects of Bifidobacterium species in colon
cancer cells and a mouse model of carcinogenesis. PLoS One 2020;15:e0232930. DOI PubMed PMC
8. Yoon Y, Kim G, Jeon BN, Fang S, Park H. Bifidobacterium strain-specific enhances the efficacy of cancer therapeutics in tumor-
bearing mice. Cancers 2021;13:957. DOI PubMed PMC
9. Wu J, Wang S, Zheng B, Qiu X, Wang H, Chen L. Modulation of gut microbiota to enhance effect of checkpoint inhibitor
immunotherapy. Front Immunol 2021;12:669150. DOI PubMed PMC
10. Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science
2015;350:1079-84. DOI PubMed PMC
11. Li W, Zhang Z, Liu J, et al. Nanodrug-loaded Bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-
targeted photodynamic and sonodynamic synergistic therapy. Acta Biomater 2022;146:341-56. DOI
12. Benito I, Encío IJ, Milagro FI, et al. Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in combination with
quercetin inhibit colorectal cancer development in Apc Min/+ mice. Int J Mol Sci 2021;22:4906. DOI PubMed PMC
13. Hill C, Guarner F, Reid G, et al. Expert consensus document. The international scientific association for probiotics and prebiotics
consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14. DOI
14. Gleinser M, Grimm V, Zhurina D, Yuan J, Riedel CU. Improved adhesive properties of recombinant bifidobacteria expressing the
Bifidobacterium bifidum-specific lipoprotein BopA. Microb Cell Fact 2012;11:80. DOI PubMed PMC